Literature DB >> 7399703

Antibody responses to toxoplasma antigens in mice infected with strains of different virulence.

E Handman, J S Remington.   

Abstract

Swiss Webster mice were infected with either the relatively virulent C56 strain or the relatively avirulent C37 strain of Toxoplasma gondii, and the sequence of their antibody response to surface antigens of the parasite was studied. An immunoglobulin M (IgM) agglutinating antibody was the first serologically detectable antibody and was first detected on day 2 in mice infected with the C37 strain and on day 5 in mice infected with the C56 strain. IgG antibodies were first detected on day 8 for both strains. The major component of the IgG antibodies was IgG2:IgG3 antibodies had lower titers, and no IgG1 antibodies were detected. The IgG antibodies were active in direct parasite agglutination and in the complement-dependent cytotoxicity assay of Sabin and Feldman (Science 108:660-663, 1948). On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, sera from mice infected with T. gondii detected all major radioiodinated surface proteins of toxoplasma tachyzoites. The earliest time point at which these antigens were detected differed for the two strains. Serum from mice infected with C56 strain immunoprecipitated all cell surface antigens by day 10 of infection, whereas serum from mice infected with the C37 strain did not do so until day 15 of infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399703      PMCID: PMC551098          DOI: 10.1128/iai.29.1.215-220.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Enhanced autoradiographic detection of 32P and 125I using intensifying screens and hypersensitized film.

Authors:  R A Laskey; A D Mills
Journal:  FEBS Lett       Date:  1977-10-15       Impact factor: 4.124

3.  Comparison of the indirect fluorescent antibody test and methylene blue dye test for detection of antibodies to Toxoplasma gondii.

Authors:  B C Walton; B M Benchoff; W H Brooks
Journal:  Am J Trop Med Hyg       Date:  1966-03       Impact factor: 2.345

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Comparison of three strains of Toxoplasma gondii by polyacrylamide-gel electrophoresis.

Authors:  M M Bloomfield; J S Remington
Journal:  Trop Geogr Med       Date:  1970-09

6.  Conjugation of antibodies with fluorochromes: modifications to the standard methods.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

7.  Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity.

Authors:  G Desmonts; J S Remington
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

8.  Trypanosoma gambiense and T. equiperdum: characterization of variant specific antigens.

Authors:  J R Seed
Journal:  Exp Parasitol       Date:  1972-02       Impact factor: 2.011

9.  Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter.

Authors:  D R Parks; V M Bryan; V T Oi; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

10.  Analysis of H-2 and Ia molecules by two-dimensional gel electrophoresis.

Authors:  P P Jones
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  13 in total

1.  Expression, characterization, and serologic reactivity of recombinant surface antigen P22 of Toxoplasma gondii.

Authors:  S F Parmley; G D Sgarlato; J Mark; J B Prince; J S Remington
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Kinetics study and characterisation of target excreted/secreted antigens of immunoglobulin G, M, A and E antibodies from mice infected with different strains of Toxoplasma gondii.

Authors:  P Cazabonne; M H Bessieres; J P Seguela
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

3.  Detection of immunoglobulin M antibodies with antigen-tagged latex particles in an immunosorbent assay.

Authors:  J S Remington; W M Eimstad; F G Araujo
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

4.  Identification of immunogenic outer membrane proteins of Haemophilus influenzae type b in the infant rat model system.

Authors:  E J Hansen; C F Frisch; R L McDade; K H Johnston
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Strain-specific antigens of Toxoplasma gondii.

Authors:  P L Ware; L H Kasper
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

6.  Partially purified antigen preparations of Toxoplasma gondii protect against lethal infection in mice.

Authors:  F G Araujo; J S Remington
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Differentiation between mouse-virulent and -avirulent strains of Toxoplasma gondii by a monoclonal antibody recognizing a 27-kilodalton antigen.

Authors:  W Bohne; U Gross; J Heesemann
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

8.  Antigen analysis of several pathogenic strains of Trichomonas vaginalis.

Authors:  J F Alderete
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

Review 9.  Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Authors:  E Y Denkers; R T Gazzinelli
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

10.  Cross-reacting human and rabbit antibodies to antigens of Histoplasma capsulatum, Candida albicans, and Saccharomyces cerevisiae.

Authors:  B V Kumar; G Medoff; G S Kobayashi; W L Sieling
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.